The Lancet Gastroenterology & Hepatology in conversation with

Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma

August 04, 2022 The Lancet Gastroenterology & Hepatology
Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma
The Lancet Gastroenterology & Hepatology in conversation with
More Info
The Lancet Gastroenterology & Hepatology in conversation with
Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma
Aug 04, 2022
The Lancet Gastroenterology & Hepatology

Edward Kim (Icahn School of Medicine at Mount Sinai) discusses the single-arm RASER study of radiation segmentectomy for patients with unresectable very early to early stage hepatocellular carcinoma.

Read the full article:
Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Show Notes

Edward Kim (Icahn School of Medicine at Mount Sinai) discusses the single-arm RASER study of radiation segmentectomy for patients with unresectable very early to early stage hepatocellular carcinoma.

Read the full article:
Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv